FTFinancial Times·3hBusiness
score+0.30
AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
Original
AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
“The headline uses factual, transactional language describing a potential merger, lacking overt emotional valence or alarmist framing.”